SEC 13F Intelligence

Choate Investment Advisors / ABT

Choate Investment Advisors’s Abbott Laboratories Position

Does Choate Investment Advisors own Abbott Laboratories (ABT)? Yes — 304.2K shares worth $31M (+0.61% of its 13F portfolio) as of Q1 2026, down from 306.0K shares the prior filed quarter.

Position Value
$31M
Q1 2026
Shares
304.2K
% of Portfolio
+0.61%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $8MQ2 ’19: $8MQ3 ’19: $8MQ4 ’19: $8MQ4 ’19Q1 ’20: $7MQ2 ’20: $8MQ3 ’20: $10MQ4 ’20: $10MQ4 ’20Q1 ’21: $11MQ2 ’21: $11MQ3 ’21: $11MQ4 ’21: $14MQ4 ’21Q1 ’22: $12MQ2 ’22: $11MQ3 ’22: $10MQ4 ’22: $12MQ4 ’22Q1 ’23: $12MQ2 ’23: $13MQ3 ’23: $12MQ4 ’23: $17MQ4 ’23Q1 ’24: $20MQ2 ’24: $18MQ3 ’24: $20MQ4 ’24: $23MQ4 ’24Q1 ’25: $31MQ2 ’25: $36MQ3 ’25: $37MQ4 ’25: $38MQ4 ’25Q1 ’26: $31Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026304.2K$31M+0.61%
Q4 2025306.0K$38M+0.75%
Q3 2025280.0K$37M+0.78%
Q2 2025263.1K$36M+0.78%
Q1 2025232.0K$31M+0.76%
Q4 2024206.7K$23M+0.56%
Q3 2024178.5K$20M+0.52%
Q2 2024172.4K$18M+0.47%
Q1 2024175.5K$20M+0.54%
Q4 2023158.8K$17M+0.54%
Q3 2023126.0K$12M+0.48%
Q2 2023121.5K$13M+0.55%
Q1 2023113.7K$12M+0.56%
Q4 2022108.9K$12M+0.72%
Q3 2022107.6K$10M+0.69%
Q2 2022104.5K$11M+0.69%
Q1 202298.8K$12M+0.62%
Q4 202198.4K$14M+0.81%
Q3 202193.8K$11M+0.71%
Q2 202194.4K$11M+0.66%
Q1 202191.6K$11M+0.68%
Q4 202091.1K$10M+0.61%
Q3 202091.5K$10M+0.65%
Q2 202092.1K$8M+0.61%
Q1 202094.2K$7M+0.59%
Q4 201996.4K$8M+0.51%
Q3 201996.5K$8M+0.50%
Q2 201997.8K$8M+0.49%
Q1 201999.5K$8M+0.47%
Q4 201898.1K$7M+0.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Choate Investment Advisors’s full portfolio or all institutional holders of ABT.